| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 33 |
| 1 | ADALIMUMAB | 30 |
| 2 | METHOTREXATE | 29 |
| 3 | ASPIRIN | 23 |
| 4 | ASPIRIN 325 MG | 21 |
| 5 | ASPIRIN 81 MG | 21 |
| 6 | CARBOPLATIN | 19 |
| 7 | ETOPOSIDE | 19 |
| 8 | FUROSEMIDE | 18 |
| 9 | INFLIXIMAB | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 10 | 0.0008 |
| 1 | ERGOCALCIFEROL | 13 | 0.0004 |
| 2 | ETOPOSIDE | 19 | 0.0003 |
| 3 | ATEZOLIZUMAB | 9 | 0.0002 |
| 4 | CARBOPLATIN | 19 | 0.0001 |
| 5 | CLOZAPINE | 12 | 0.0001 |
| 6 | SULFASALAZINE | 7 | 0.0001 |
| 7 | CISPLATIN | 7 | 0.0001 |
| 8 | LEVOTHYROXINE SODIUM ANHYDROUS | 9 | 0.0001 |
| 9 | LEFLUNOMIDE | 9 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 45 |
| 1 | Corticosteroid [EPC] | 41 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 39 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 25 |
| 5 | Platinum-based Drug [EPC] | 23 |
| 6 | Benzodiazepine [EPC] | 22 |
| 7 | Proton Pump Inhibitor [EPC] | 21 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 20 |
| 9 | Loop Diuretic [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 1 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 5 | 0.0003 |
| 3 | Bile Acid Sequestrant [EPC] | 4 | 0.0003 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 4 | 0.0003 |
| 5 | Topoisomerase Inhibitor [EPC] | 20 | 0.0003 |
| 6 | Stimulant Laxative [EPC] | 3 | 0.0002 |
| 7 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 8 | Integrin Receptor Antagonist [EPC] | 15 | 0.0002 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |